SCHEMBL188388

SCHEMBL188388

CSc1ncc2c(=O)n3c(nc2n1)c1ccccc1n3-c1ncccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
RPS6KA5 O75582 1/20 0.35
KDM4E B2RXH2 2/20 0.32
MAPT P10636 2/20 0.32
LMNA P02545 1/20 0.32
DPP4 P27487 1/20 0.31
PMM2 O15305 1/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31
G6PD P11413 1/20 0.31
PKM P14618 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
ALOX12 P18054 1/20 0.31
MAPK1 P28482 1/20 0.31
MPI P34949 1/20 0.31
EP300 Q09472 1/20 0.31
KAT2A Q92830 1/20 0.31
KAT2B Q92831 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL188485 0.89 MEN1 (0.40) MEN1KMT2ARPS6KA5KDM4EMAPT
SCHEMBL188840 0.87 MEN1 (0.40) MEN1KMT2ARPS6KA5KDM4EMAPT
SCHEMBL188453 0.86 NPSR1 (0.39) MEN1KMT2ARPS6KA5KDM4EMAPT
SCHEMBL188238 0.85 MEN1 (0.39) MEN1KMT2ARPS6KA5KDM4EALDH1A1
SCHEMBL188582 0.85 MEN1 (0.39) MEN1KMT2ARPS6KA5KDM4EALDH1A1
SCHEMBL217160 0.85 MEN1 (0.40) MEN1KMT2ARPS6KA5KDM4EMAPT
SCHEMBL213398 0.84 MEN1 (0.38) MEN1KMT2ARPS6KA5KDM4EMAPT
SCHEMBL216481 0.84 KMT2A (0.38) MEN1KMT2ARPS6KA5KDM4EMAPT
SCHEMBL188207 0.84 MEN1 (0.39) MEN1KMT2AKDM4EMAPTLMNA
SCHEMBL188721 0.84 MEN1 (0.44) MEN1KMT2ARPS6KA5KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288396-B2 Pyrimidopyrimidoindazole derivative MSDKK (JP) 2012-10-16 US disclosed
US-20120134955-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE MSD K.K. (JP) 2012-05-31 US disclosed
EP-2401281-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE MSD K.K. (JP) 2012-01-04 EP disclosed
WO-2010098367-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120134955-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE WEE1, WEE2, DCK MEN1 3601/4885KMT2A 3701/4885RPS6KA5 149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.